Evidence map›Paper›PMID 28412978›Full record

ReviewAlzheimer's research & therapy2017

The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group.

Alberto Costa, Thomas Bak, Paolo Caffarra, Carlo Caltagirone, Mathieu Ceccaldi, Fabienne Collette, Sebastian Crutch, Sergio Della Sala, Jean François Démonet, Bruno Dubois and 9 more

Open access · goldAbstract readConsensus StatementReview
In one paragraph

Review in Alzheimer's research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 5 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 5 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Driving and Alzheimer's dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist's role.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Usability and user experience of tablet-based teleneuropsychology platform for the diagnosis of mild cognitive impairment: the Italian experience.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  10. The Shifting Treatment Landscape for Alzheimer's Disease in Primary Care.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 17 institutions in 8 countries.

Alberto CostaNiccolò Cusano University, via Don Carlo Gnocchi, 3, Rome, Italy. alberto.costa@unicusano.it.
Thomas BakUniversity of Edinburgh, 7 George Square, EH8 9JZ, Edinburgh, Scotland, UK.
Paolo CaffarraUniversity of Parma, Via Gramsci, 14, Parma, Italy.
Carlo CaltagironeIRCCS Fondazione Santa Lucia, via Ardeatina 354, Rome, Italy.
Mathieu CeccaldiUniversity Hospital La Timone, 264 Rue Saint-Pierre, Marseille, France.
Fabienne ColletteNational Fund for Scientific Research (F.R.S-FNRS), Quartier Agora place des Orateurs 1, Liège, Belgium.
Sebastian CrutchDementia Research Centre, UCL Institute of Neurology, University College of London, Queen Square, WC1N 3BG, London, UK.
Sergio Della SalaIRCCS Fondazione Santa Lucia, via Ardeatina 354, Rome, Italy.
Jean François DémonetLeenaards Memory Centre CHUV, Lausanne University Hospital, Rue du Bugnon 46, Lausanne, Switzerland.
Bruno DuboisInstitut de la Mémoire et de la Maladie d'Alzheimer (IMMA), Hôpital de la Pitié-Salpêtrière, 47-83 Boulevard de l'Hôpital, Paris, France.
Emrah DuzelDementia Research Centre, UCL Institute of Neurology, University College of London, Queen Square, WC1N 3BG, London, UK.
Peter NestorGerman Center for Neurodegenerative Diseases (DZNE), Holbeinstraße 13-15, Bonn, Germany.
Sokratis G PapageorgiouMedical School, National and Kapodistrian University of Athens, Rimini street, 124 62, Haidari, Athens, Greece.
Eric SalmonCyclotron Research Centre, University of Liege, Allée du VI août, 8, Liège, Belgium.
Sietske SikkesAlzheimer Center/dpt Neurology, VU University Medical Center of Amsterdam, Amsterdam Neuroscience, De Boelelaan 1118, Amsterdam, The Netherlands.
Pietro TiraboschiFondazione IRCCS Istituto Neurologico Carlo Besta, Via Giovanni Celoria, 11, Milan, Italy.
Wiesje M van der FlierAlzheimer Center/dpt Neurology, VU University Medical Center of Amsterdam, Amsterdam Neuroscience, De Boelelaan 1118, Amsterdam, The Netherlands.
Pieter Jelle VisserMaastricht University Medical Centre, Dr. Tanslaan 12, Maastricht, The Netherlands.
Stefano F CappaIUSS Pavia, Piazza della Vittoria 15, 27100, Pavia, Italy.
Amsterdam Neuroscience · NLUniversity of Liège · BEAix-Marseille Université · FRFondazione IRCCS Istituto Neurologico Carlo Besta · ITFondazione Santa Lucia · ITGerman Center for Neurodegenerative Diseases · DEIstituto Universitario di Studi Superiori di Pavia · ITMaastricht University Medical Centre · NLNational and Kapodistrian University of Athens · GRNational Hospital for Neurology and Neurosurgery · GBSorbonne Université · FRUK Dementia Research Institute · GBUniversity Niccolò Cusano · ITUniversity of Edinburgh · GBUniversity of Lausanne · CHUniversity of Parma · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive, behavioural, and functional assessment is crucial in longitudinal studies of neurodegenerative dementias (NDD). Central issues, such as the definition of the study population (asymptomatic, at risk, or individuals with dementia), the detection of change/decline, and the assessment of relevant outcomes depend on quantitative measures of cognitive, behavioural, and functional status.Currently, we are far from having available reliable protocols and tools for the assessment of dementias in Europe. The main problems are the heterogeneity of the tools used across different European countries, the lack of standardisation of administration and scoring methods across centres, and the limited information available about the psychometric properties of many tests currently in widespread use. This situation makes it hard to compare results across studies carried out in different centres, thus hampering research progress, in particular towards the contribution to a "big data" common data set.We present here the results of a project funded by the Joint Program for Neurodegenerative Diseases (JPND) and by the Italian Ministry of Health. The project aimed at providing a consensus framework for the harmonisation of assessment tools to be applied to research in neurodegenerative disorders affecting cognition across Europe. A panel of European experts reviewed the current methods of neuropsychological assessment, identified pending issues, and made recommendations for the harmonisation of neuropsychological assessment of neurodegenerative dementias in Europe.A consensus was achieved on the general recommendations to be followed in developing procedures and tools for neuropsychological assessment, with the aim of harmonising tools and procedures to achieve more reliable data on the cognitive-behavioural examination. The results of this study should be considered as a first step to enhancing a common view and practise on NDD assessment across European countries.

Indexed as

Neuropsychological TestsDementiaEuropeHumansBehavioural assessmentCognitive assessmentEuropean researchLongitudinal studiesNeurodegenerative dementiaNeuropsychological tests

Identifiers

PMID28412978
PMCPMC5392959
OpenAlexW2605747520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.